343 related articles for article (PubMed ID: 16418779)
1. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function.
Humphrey MB; Daws MR; Spusta SC; Niemi EC; Torchia JA; Lanier LL; Seaman WE; Nakamura MC
J Bone Miner Res; 2006 Feb; 21(2):237-45. PubMed ID: 16418779
[TBL] [Abstract][Full Text] [Related]
2. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.
Humphrey MB; Ogasawara K; Yao W; Spusta SC; Daws MR; Lane NE; Lanier LL; Nakamura MC
J Bone Miner Res; 2004 Feb; 19(2):224-34. PubMed ID: 14969392
[TBL] [Abstract][Full Text] [Related]
3. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
4. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
Koga T; Inui M; Inoue K; Kim S; Suematsu A; Kobayashi E; Iwata T; Ohnishi H; Matozaki T; Kodama T; Taniguchi T; Takayanagi H; Takai T
Nature; 2004 Apr; 428(6984):758-63. PubMed ID: 15085135
[TBL] [Abstract][Full Text] [Related]
5. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.
Peng Q; Malhotra S; Torchia JA; Kerr WG; Coggeshall KM; Humphrey MB
Sci Signal; 2010 May; 3(122):ra38. PubMed ID: 20484116
[TBL] [Abstract][Full Text] [Related]
6. CSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway.
Wei R; Zhang L; Hu W; Wu J; Zhang W
Biochem Biophys Res Commun; 2022 Oct; 627():12-20. PubMed ID: 36007331
[TBL] [Abstract][Full Text] [Related]
7. High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.
Faccio R; Zou W; Colaianni G; Teitelbaum SL; Ross FP
J Cell Biochem; 2003 Dec; 90(5):871-83. PubMed ID: 14624447
[TBL] [Abstract][Full Text] [Related]
8. Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis.
Kim HS; Kim DK; Kim AR; Mun SH; Lee SK; Kim JH; Kim YM; Choi WS
Cell Signal; 2012 Jun; 24(6):1306-14. PubMed ID: 22387224
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930
[TBL] [Abstract][Full Text] [Related]
10. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
Paloneva J; Mandelin J; Kiialainen A; Bohling T; Prudlo J; Hakola P; Haltia M; Konttinen YT; Peltonen L
J Exp Med; 2003 Aug; 198(4):669-75. PubMed ID: 12925681
[TBL] [Abstract][Full Text] [Related]
11. Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function.
Feng X; Takeshita S; Namba N; Wei S; Teitelbaum SL; Ross FP
Endocrinology; 2002 Dec; 143(12):4868-74. PubMed ID: 12446614
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.
Zawawi MS; Dharmapatni AA; Cantley MD; McHugh KP; Haynes DR; Crotti TN
Biochem Biophys Res Commun; 2012 Oct; 427(2):404-9. PubMed ID: 23000414
[TBL] [Abstract][Full Text] [Related]
13. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.
Mócsai A; Humphrey MB; Van Ziffle JA; Hu Y; Burghardt A; Spusta SC; Majumdar S; Lanier LL; Lowell CA; Nakamura MC
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6158-63. PubMed ID: 15073337
[TBL] [Abstract][Full Text] [Related]
15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
16. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
17. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
[TBL] [Abstract][Full Text] [Related]
19. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
Humphrey MB; Nakamura MC
Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
